收藏該雜志
同大類學(xué)科其它級別期刊：
中科院 1區(qū) 期刊 JCR Q1 期刊 中科院 2區(qū) 期刊 JCR Q2 期刊 中科院 3區(qū) 期刊 JCR Q3 期刊 中科院 4區(qū) 期刊 JCR Q4 期刊Breast Cancer-targets And Therapy SCIE
國際簡稱：BREAST CANCER-TARGET 參考譯名：乳腺癌-靶點和治療
主要研究方向：ONCOLOGY 非預(yù)警期刊 審稿周期： 16 Weeks
《乳腺癌-靶點和治療》(Breast Cancer-targets And Therapy)是一本由Dove Medical Press出版的以O(shè)NCOLOGY為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預(yù)警名單。
"Breast Cancer: Targets and Therapy," with its open-access nature, provides a valuable resource for medical researchers, clinicians, and patients with breast cancer. The journal covers comprehensive research from basic biological mechanisms to clinical applications, committed to promoting innovation and progress in the field of breast cancer treatment.
The journal pays special attention to precision medicine and personalized treatment plans, emphasizing in-depth research on molecular targets of breast cancer and how to translate these research findings into effective clinical treatments. In addition, the journal encourages the publication of research on new drug development, drug sensitivity, resistance mechanisms, and new therapeutic technologies, aiming to provide more treatment options for patients with breast cancer.
Breast Cancer-targets And Therapy期刊信息
- ISSN：1179-1314
- 出版語言：English
- 是否OA：開放
- E-ISSN：1179-1314
- 出版地區(qū)：United Kingdom
- 是否預(yù)警：否
- 出版商：Dove Medical Press
- 出版周期：1 issue/year
- 開源占比：0.9752
- Gold OA文章占比：98.22%
- OA被引用占比：1
- 出版國人文章占比：0.03
- 出版撤稿占比：
- 研究類文章占比：77.33%
Breast Cancer-targets And Therapy CiteScore評價數(shù)據(jù)（2024年最新版）
| CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||
| 4.1 | 0.933 | 1.009 |
|
名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當(dāng)年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量 注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。
Breast Cancer-targets And Therapy中科院評價數(shù)據(jù)
中科院 2023年12月升級版
| Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
| 否 | 否 | 醫(yī)學(xué) | 4區(qū) | ONCOLOGY 腫瘤學(xué) | 4區(qū) |
中科院 2022年12月升級版
| Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
| 否 | 否 | 醫(yī)學(xué) | 4區(qū) | ONCOLOGY 腫瘤學(xué) | 4區(qū) |
Breast Cancer-targets And Therapy JCR評價數(shù)據(jù)（2023-2024年最新版）
| 按JIF指標學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學(xué)科：ONCOLOGY | SCIE | Q2 | 118 / 322 |
63.5% |
| 按JCI指標學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學(xué)科：ONCOLOGY | SCIE | Q3 | 186 / 322 |
42.39% |
Breast Cancer-targets And Therapy歷年數(shù)據(jù)統(tǒng)計
影響因子
中科院分區(qū)
Breast Cancer-targets And Therapy中國學(xué)者發(fā)文選摘
-
1、Critical Evaluation of Secondary Cancer Risk After Breast Radiation Therapy with Hybrid Radiotherapy Techniques
Author: Zhang, Quanbin; Zeng, Yu; Peng, Yingying; Yu, Hui; Zhang, Shuxu; Wu, Shuyu
Journal: BREAST CANCER-TARGETS AND THERAPY. 2023; Vol. 15, Issue , pp. 25-38. DOI: 10.2147/BCTT.S383369
-
2、An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
Author: Zhang, Mengqi; Bao, Shengxian; Qiu, Guanhua; Liang, Jingchen; Wang, Qin; Zhu, Xiaoqi; Qin, Guchun; Liu, Junjie; Zhao, Chang
Journal: BREAST CANCER-TARGETS AND THERAPY. 2023; Vol. 15, Issue , pp. 101-119. DOI: 10.2147/BCTT.S387793
-
3、Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review
Author: Wu, Jing; Jin, Yudi; Liu, Mei; Zhu, Ningsheng; Jing, Zhouhong; Zeng, Xiaohua
Journal: BREAST CANCER-TARGETS AND THERAPY. 2023; Vol. 15, Issue , pp. 39-45. DOI: 10.2147/BCTT.S395944
-
4、Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review
Author: Wang, Jin; Liao, Dongying; Zhang, Xuemin; Miao, Changhong; Chen, Kuang
Journal: BREAST CANCER-TARGETS AND THERAPY. 2023; Vol. 15, Issue , pp. 281-294. DOI: 10.2147/BCTT.S407181
-
5、Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients
Author: Shen, Jun; Yan, Huanhuan; Yang, Congying; Lin, Haiyue; Li, Fan; Zhou, Jun
Journal: BREAST CANCER-TARGETS AND THERAPY. 2023; Vol. 15, Issue , pp. 295-310. DOI: 10.2147/BCTT.S402109
-
6、Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
Author: Ma, Jing; Dong, Chao; Cao, Yan-Zhen; Ma, Bin-Lin
Journal: BREAST CANCER-TARGETS AND THERAPY. 2023; Vol. 15, Issue , pp. 11-24. DOI: 10.2147/BCTT.S390017
-
7、The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis
Author: Liao, Yuqian; Liao, Yulu; Li, Jun; Li, Yong; Fan, Ying
Journal: BREAST CANCER-TARGETS AND THERAPY. 2023; Vol. 15, Issue , pp. 135-146. DOI: 10.2147/BCTT.S395984
-
8、Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in Breast Cancer
Author: Li, Ning; Song, Chao; Huang, Xian; Zhang, Hongjiang; Su, Juan; Yang, Lichun; He, Juhua; Cui, Guihua
Journal: BREAST CANCER-TARGETS AND THERAPY. 2023; Vol. 15, Issue , pp. 121-132. DOI: 10.2147/BCTT.S398300
Breast Cancer-targets And Therapy同類期刊
-
公共衛(wèi)生前沿
Frontiers In Public Health
中科院 3區(qū) JCR Q2
-
藥理學(xué)前沿
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
-
生物醫(yī)學(xué)與藥物治療
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
-
探索腫瘤學(xué)
Discover Oncology
中科院 4區(qū) JCR Q2
-
Bmc精神病學(xué)
Bmc Psychiatry
中科院 2區(qū) JCR Q2
-
Bmc神經(jīng)病學(xué)
Bmc Neurology
中科院 3區(qū) JCR Q3
-
材料化學(xué)雜志 B
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1
-
美康
Medcomm
中科院 3區(qū) JCR Q1
免責(zé)聲明